FortuneRock(China) Raises $24 Million for Protein Drug Development

FortuneRock (China), a Beijing developer of novel protein drugs, raised $24 million from China investors. The company will use $19.5 million of the capital to build a GMP production facility in Tianjin, which it will spin off into a new company. The remainder is allocated toward pre-IPO and other general corporate expenses. FortuneRock(China) uses two proprietary platforms to generate novel molecules: one produces timed-release recombinant protein molecules and the other is a high-efficacy yeast expression system. More details.... Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.